AlphaCentric Advisors »

Boston Scientific Corporation shares owned by AlphaCentric Advisors

Quarter-by-quarter ownership of Boston Scientific Corporation (BSX) shares owned by AlphaCentric Advisors from 13F filings

Historical chart of AlphaCentric Advisors investment in Boston Scientific Corporation

Tip: Access up to 7 years of quarterly data

All positions including Boston Scientific Corporation held by AlphaCentric Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Boston Scientific Corporation by AlphaCentric Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $229k 3.3k 68.49
2023-09-30 $221k 4.2k 52.80
2023-06-30 $236k 4.4k 54.09

More positions owned by AlphaCentric Advisors

Pfizer (PFE)
Rithm Capital Corp Com New (RITM)
Harmony Biosciences Hldgs In (HRMY)
United Therapeutics Corporation (UTHR)
Pacira Pharmaceuticals (PCRX)
BioCryst Pharmaceuticals (BCRX)
Galapagos Nv Spon Adr (GLPG)
Argenx Se Sponsored Adr (ARGX)
Two Harbors Inventment Corpo Note 6.250% 1/1
Inari Medical Ord (NARI)
Docgo (DCGO)
Beigene Sponsored Adr (BGNE)
Ellington Financial Inc ellington financ (EFC)
Axsome Therapeutics (AXSM)
MGIC Investment (MTG)

View all positions for AlphaCentric Advisors

Top funds holding Boston Scientific Corporation

Vanguard Group
Massachusetts Financial Services
PRIMECAP Management Company
Wellington Management Company
Bank of America Corporation
Jpmorgan Chase & Co
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Henderson Group
Artisan Partners Limited Partnership
Goldman Sachs Group
Norges Bank Investment Management
Bank of New York Mellon
Amundi
Legal & General Group
Vontobel Asset Management

View all funds holding Boston Scientific Corporation